VanEck Pharmaceutical ETF

VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETFUS flagNASDAQ Global Market
- -
USD
- -
- -

VanEck Pharmaceutical ETF (PPH) Stock Splits

Learn about VanEck Pharmaceutical ETF's most recent 2-for-1 basis stock split on February 14, 2012. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about VanEck Pharmaceutical ETF's most recent stock split

Split Date: 2012-02-14
Split Ratio: 2:1
Price Before Split: N/A
Price After Split: N/A

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 2.00 times more shares (a 2:1 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of VanEck Pharmaceutical ETF's stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2012-02-142:1NoN/AN/A

About VanEck Pharmaceutical ETF

Company overview and industry information

VanEck Pharmaceutical ETF (PPH) operates in the Asset Management industry. The recent 2-for-1 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Asset Management
Go to VanEck Pharmaceutical ETF Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.